Publications

Estimating baseline rates of adverse perinatal and neonatal outcomes using a facility-based surveillance approach: A prospective observational study from the WHO Global Vaccine Safety Multi-Country Collaboration on safety in pregnancy.

Sharan, A; Stuurman, AL; Jahagirdar, S; Elango, V; Riera-Montes, M; Kashyap, NK; Biccler, J; Poluru, R; Arora, NK; Mathai, M; MANGTANI, P; Devlieger, H; Anderson, S; Whitaker, B; Wong, H-L; Moran, A; Maure, CG; WHO Global Vaccine Safety Multi-Country Collaborat,;

2022

EClinicalMedicine, (2022).50, 10.1016/j.eclinm.2022.101506.

Pneumococcal conjugate vaccination schedules in infants-acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study.

MACKENZIE, GA; OSEI, I; Salaudeen, R; Secka, O; D'ALESSANDRO, U; CLARKE, E; Schmidt-Chanasit, J; Licciardi, PV; Nguyen, C; GREENWOOD, B; Mulholland, K;

2022

TRIALS, (2022).23 1 10.1186/s13063-021-05949-4.

Vaccine Equity in Low and Middle Income Countries: A Systematic Review and Meta-analysis.

Ali, H; Hartner, A-M; Echeverria-Londono, S; Roth, J; Li, X; ABBAS, K; Portnoy, A; Vynnycky, E; Woodruff, K; Ferguson, N; Toor, J; Gaythorpe, KA M;

2022

medRxiv (2022). 10.1101/2022.03.23.22272812.

Multiplex Serology for Measurement of IgG Antibodies Against Eleven Infectious Diseases in a National Serosurvey: Haiti 2014-2015.

Chan, Y; Martin, D; Mace, KE; Jean, SE; STRESMAN, G; DRAKELEY, C; Chang, MA; Lemoine, JF; Udhayakumar, V; Lammie, PJ; Priest, JW; Rogier, EW;

2022

Frontiers in Public Health, (2022).10, 10.3389/fpubh.2022.897013.

Women's views on accepting COVID-19 vaccination during and after pregnancy, and for their babies: a multi-methods study in the UK.

Skirrow, H; Barnett, S; BELL, S; Riaposova, L; MOUNIER-JACK, S; KAMPMANN, B; Holder, B;

2022

BMC pregnancy and childbirth, (2022).22 1 10.1186/s12884-021-04321-3.

Add-Vacc trial.

WATSON-JONES, D;

2022

(2022).

Non-COVID-19 vaccine hesitancy among migrant populations worldwide: a scoping review of the literature, 2000-2020.

Tankwanchi, AS; Jaca, A; Ndlambe, AM; Zantsi, ZP; Bowman, B; Garrison, MM; LARSON, HJ; Vermund, SH; Wiysonge, CS;

2022

Expert review of vaccines, (2022).21 9 10.1080/14760584.2022.2084075.

COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery.

Toor, J; Li, X; JIT, M; Trotter, C; Echeverria-Londono, S; Hartner, A-M; Roth, J; Portnoy, A; Abbas, K; Ferguson, N; Gaythorpe, KA M;

2022

medRxiv (2022). 10.1101/2022.01.07.22268891.

Solidarity COVID-19 vaccine trial.

WATSON-JONES, D;

2022

(2022).

End-point definition and trial design to advance tuberculosis vaccine development.

Garcia-Basteiro, AL; WHITE, RG; Tait, D; Schmidt, AC; Rangaka, MX; Quaife, M; Nemes, E; Mogg, R; Hill, PC; Harris, RC; Hanekom, WA; Frick, M; Fiore-Gartland, A; Evans, T; Dagnew, AF; Churchyard, G; Cobelens, F; Behr, MA; Hatherill, M;

2022

European respiratory review, (2022).31 164 10.1183/16000617.0044-2022.